ExodusPoint Capital Management, LP
Position in CTKB — Cytek Biosciences, Inc.
CIK 1736225
NEW YORK, NY
Position in CTKB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$160,100
-$58,405 QoQ
Shares Held
36,140
-42.6% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 154 holders
Holding Since
Mar 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CTKB Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $464,643,980 across 33 Medical Devices names. CTKB ranks #28 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
1,090,430 | $344,303,272 | |
| 2 | BSX |
Boston Scientific Corp
|
504,948 | $21,551,180 | |
| 3 | LIVN |
LivaNova PLC
|
207,801 | $17,087,476 | |
| 4 | ZBH |
Zimmer Biomet Holdings, Inc.
|
180,884 | $15,572,303 | |
| 5 | TNDM |
Tandem Diabetes Care Inc
|
691,789 | $10,439,096 | |
| 6 | ABT |
Abbott Laboratories
|
109,826 | $9,965,611 | |
| 7 | DXCM |
Dexcom Inc
|
116,548 | $7,849,507 | |
| 8 | BFLY |
Butterfly Network, Inc.
|
761,861 | $6,414,869 |
All Filings in CTKB
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $160,100 | 36,140 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $218,505 | 62,970 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $797,969 | 234,697 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $503,208 | 77,536 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $660,600 | 119,242 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $206,649 | 37,034 | Shares | Sole | 2024-08-13 | |
| 2023-03-31 | $1,100,686 | 119,770 | Shares | Sole | 2023-05-11 | |
| 2022-03-31 | $291,588 | 27,049 | Shares | Other | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||